Phase 1 Carcinoma, Non-Small Cell Lung Clinical Trials

3 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–3 of 3 trials

Recruiting

Phase 1

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

Carcinoma, Non-Small Cell LungSquamous Cell Carcinoma of Head and NeckHER2 Negative Breast Neoplasms+9 more

Seagen, a wholly owned subsidiary of Pfizer1,006 enrolled154 locationsNCT04389632

Recruiting

Phase 1Phase 2

A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers

Carcinoma, Non-Small Cell LungAdvanced/Metastatic Non-Small Cell Lung Cancer

Pfizer162 enrolled5 locationsNCT07227298

Recruiting

Phase 1Phase 2

Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib

Carcinoma, Non-Small Cell Lung

Genprex, Inc.158 enrolled10 locationsNCT04486833